Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells.

about

Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells.

Item

http://www.wikidata.org/entity/Q47809269

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@en

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@nl

type

Item

label

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@en

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@nl

prefLabel

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@en

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@nl

P1476

Determinants for Effective ALE ...... rived Glioblastoma Stem Cells.

@en

P2093

Anja Smits

http://www.w3.org/2001/XMLSchema#string

Anna Wenger

http://www.w3.org/2001/XMLSchema#string

Bertil Rydenhag

http://www.w3.org/2001/XMLSchema#string

Dan Farahmand

http://www.w3.org/2001/XMLSchema#string

Magnus Tisell

http://www.w3.org/2001/XMLSchema#string

P2860

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A restricted cell population propagates glioblastoma growth after chemotherapy

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

Immune defects observed in patients with primary malignant brain tumors.

Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.

P304

25-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEO.2017.10.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29190492

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5715204

http://www.w3.org/2001/XMLSchema#string